Contact Us: 01282 426380
KM Financial Solutions | Novartis says Kisqali boosts survival in breast cancer patients
52450
post-template-default,single,single-post,postid-52450,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Novartis says Kisqali boosts survival in breast cancer patients

28 Sep Novartis says Kisqali boosts survival in breast cancer patients

Posted at 14:30h in News by
0 Likes
Novartis said on Sunday
that Kisqali helped women with advanced breast cancer after
menopause live longer, adding to data the Swiss company hopes
will help convince doctors to choose its drug over Pfizer’s
blockbuster Ibrance.

No Comments

Sorry, the comment form is closed at this time.